A randomized phase II trial of pre-chemotherapy leukine [sargramostim] vs leukine-dexamethasone in combination with gemcitabine and 5-fluorouracil in patients with metastatic renal cell carcinoma.

Trial Profile

A randomized phase II trial of pre-chemotherapy leukine [sargramostim] vs leukine-dexamethasone in combination with gemcitabine and 5-fluorouracil in patients with metastatic renal cell carcinoma.

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 24 Jun 2015

At a glance

  • Drugs Dexamethasone; Fluorouracil; Folinic acid; Gemcitabine; Sargramostim
  • Indications Renal cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 21 Aug 2006 Status change
    • 01 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top